semaglutide, Novo Nordisk

A shake-up may be brewing in the market for GLP-1 diet drugs Friday, and it's making itself felt all across the field of ...
The U.S. government has selected the second batch of drugs up for Medicare price negotiations under the Inflation Reduction ...
This week's stock market saw the S&P 500 rise 3.4%, fueled by positive inflation data and strong earnings reports.